Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 16, 2023 - Issue
Submit an article Journal homepage
186
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Health Care Situation in the Treatment of Uncontrolled GINA Step 4/5 Patients in Germany

Hartmut Timmermann1 Schwerpunktpraxis Colonnaden, Hamburg, GermanyCorrespondence[email protected]
,
Katrin Milger2 Medicine V, Ludwig-Maximilians-University (LMU) Munich, Member of the German Center for Lung Research (DZL), Comprehensive Pneumology Center Munich (CPC-M), Munich, GermanyORCID Iconhttps://orcid.org/0000-0003-2914-8773
ORCID Icon,
Johann Christian Virchow3 Abteilungen für Pneumologie / Intensivmedizin, Universitätmedizin Rostock, Rostock, Germany
,
Olaf Schmidt4 Studienzentrum KPPK, Pneumologische Gemeinschaftspraxis, Koblenz, Germany
,
Karl-Christian Bergmann5 Institute of Allergology, Charité–Universitätsmedizin, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Corporate Member of Freie Universität Berlin and Humboldt-Universität Berlin, Berlin, Germany
,
Dirk Koschel6 Fachkrankenhaus Coswig, Lung Centre, Coswig, and Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Dresden, Germany
,
Claus Neurohr7 Abteilung für Pneumologie und Beatmungsmedizin, Robert-Bosch-Krankenhaus Lungenzentrum Stuttgart, Stuttgart, Germany
,
Florian Scholz8 IQVIA Commercial GmbH & Co. OHG, Frankfurt am Main, Germany
,
Sebastian Heck9 GlaxoSmithKline GmbH & Co. KG, Munich, Germany
&
Dirk Skowasch10 Department of Internal Medicine II – Pneumology, University Hospital Bonn, Bonn, GermanyORCID Iconhttps://orcid.org/0000-0003-2377-5936
ORCID Icon show all
Pages 813-820 | Received 25 May 2023, Accepted 24 Jul 2023, Published online: 04 Aug 2023

References

  • Papaioannou AI, Kostikas K, Zervas E, et al. Control of asthma in real life: still a valuable goal? Eur Respir Rev. 2015;24(136):361–369. doi:10.1183/16000617.00001615
  • Reddel HK, Boulet LP. Global Initiative for Asthma. Global strategy for asthma management and prevention; 2021. Available from: wwwginasthmaorg. Accessed July 26, 2023.
  • Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343–373. doi:10.1183/09031936.00202013
  • Bergmann K-C, Skowasch D, Timmermann H, et al. Prevalence of patients with uncontrolled asthma despite NVL/GINA Step 4/5 treatment in Germany. J Asthma Allergy. 2022;15:897–906. doi:10.2147/JAA.S365967
  • Bergmann K-C, Skowasch D, Timmermann H, et al. Prevalence of patients with uncontrolled asthma despite high intensity treatment (NVL/GINA step 4/5) in Germany DGP congress. Pneumologie. 2022;76:S8–9.
  • Rathmann W, Bongaerts B, Carius H, et al. Basic characteristics and representativeness of the German disease analyzer database. Int J Clin Pharmacol Ther. 2018;56:459–466. doi:10.5414/CP203320
  • Bundestag WDD. Anzahl der Ärzte verschiedener Fachrichtungen Statistische Angaben zu Deutschland und ausgewählten europäischen Ländern [Number of physicians in various specialties. Statistical data on Germany and selected European countries]. German Bundestag (Deutscher Bundestag); 2019.
  • Taube C, Bramlage P, Hofer A, Anderson D. Prevalence of oral corticosteroid use in the German severe asthma population. ERJ Open Res. 2019;5:4.
  • Lommatzsch M, Wilmer C, Sauerbeck IS. Prevalence of the use of oral corticosteroids in asthma-a 3-year analysis in Germany. Eur Respir J. 2019;2019:54.
  • Hinds D, Martin S, Nelsen L, et al. Measuring burden of oral corticosteroids in us and German patients with severe asthma. Am J Respir Crit Care Med. 2018;2018:197.
  • Worth H, Criée CP, Vogelmeier CF, et al. Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany. Respir Res. 2021;22(1). doi:10.1186/s12931-021-01701-3
  • Janson C, Menzies-Gow A, Nan C, et al. SABINA: an overview of short-acting β2-agonist use in asthma in European Countries. Adv Ther. 2020;37(3):1124–1135. doi:10.1007/s12325-020-01233-0
  • Bourdin A, Quinton A, Callan L, et al. Targeted literature review: burden of disease associated with severe and uncontrolled asthma in France, Germany, Italy, Spain and the UK. Eur Respir J. 2020;56. doi:10.1183/13993003.02162-2020
  • Korn S, Koch A, Schulz C, et al. The German severe asthma registry and type 2-high and type 2-low asthma phenotypes. Eur Respir J. 2019;54.
  • Kleine-Tebbe J, Mailänder C. Patterns of allergen sensitization in patients with severe asthma in Germany. J Allergy Clin Immunol. 2020;8(2):744–746.e743.
  • Kleine-Tebbe J, Mailaender C. Epidemiological screening of severe asthma-patients with thorough allergy-testing (ESSAy). Allergy. 2018;73:707.
  • Buhl R, Koch A, Schulz C, et al. Type 2-high and type 2-low airway inflammation in severe asthma. Am J Respir Crit Care Med. 2019;199(9):489–495. doi:10.1164/rccm.201708-1668OC
  • Greulich T, Topfer V, Hennig M, et al. COPD in Germany: use of diagnostic measures including blood eosinophil counts in daily practice. Pneumologie. 2021;75(5):344–352. doi:10.1055/a-1266-6602
  • Kaur R, Chupp G. Phenotypes and endotypes of adult asthma: moving toward precision medicine. J Allergy Clin Immunol. 2019;144:1–12. doi:10.1016/j.jaci.2019.05.031

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.